GH Research (GHRS) EPS (Basic) (2020 - 2025)
GH Research (GHRS) recorded quarterly EPS (Basic) of -$0.03 in Q4 2025, up 100.0% quarter-over-quarter from -$25035.7 in Q3 2025, and down 7.65% on a YoY basis from -$0.03 in Q4 2024.
GH Research (GHRS) EPS (Basic) (2020 - 2025) Analysis & Trends
GH Research's EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.03 for Q4 2025.
- In Q4 2025, EPS (Basic) fell 7.65% year-over-year to -$0.03; the TTM figure through Dec 2025 stood at -$110089.5 (down 211325082.54% YoY), while the FY2025 annual figure was -$0.79, down 5.33% from the prior year.
- EPS (Basic) was -$0.03 for Q4 2025 at GH Research, up from -$25035.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3340.0 in Q2 2022 to a low of -$56905.3 in Q1 2025.
- Historically, EPS (Basic) has averaged -$7381.0 across 5 years, with a median of -$0.01 in 2021.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) jumped 45818927.29% in 2022, then tumbled 3545785107.7% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$0.01 in 2021, then plunged by 305.43% to -$0.05 in 2022, then tumbled by 297.67% to -$0.22 in 2023, then soared by 86.66% to -$0.03 in 2024, then decreased by 7.65% to -$0.03 in 2025.
- The last three EPS (Basic) figures came in at -$0.03 (Q4 2025), -$25035.7 (Q3 2025), and -$28148.5 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.06 |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -25,035.71 |
| Jun 30, 2025 | -28,148.48 |
| Mar 31, 2025 | -56,905.26 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -12,019.15 |
| Jun 30, 2023 | -21,469.44 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 3,340.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | -0.01 |
| Dec 31, 2020 | -0.06 |